Methylxanthines and sensorineural outcome at 14 years in children < 1501 g birthweight

Journal of Paediatrics and Child Health

Volumn 36, Issue 1, 2000, Pages 47-50

  Davis, P G ^a,b,c   Doyle, L W ^a,b,c   Rickards, A L ^c   Kelly, E A ^c   Ford, G W ^c   Davis, N M ^c   Callanan, C ^c  

^a Department Gynaecology ^*  (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Apnoea; Cerebral palsy; Newborn; Outcome

Indexed keywords

METHYLXANTHINE; THEOPHYLLINE DERIVATIVE;

ADOLESCENT; APNEA; ARTICLE; BIRTH WEIGHT; BRAIN VENTRICLE HEMORRHAGE; CEREBRAL PALSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM; NEWBORN PERIOD; OUTCOMES RESEARCH; PREMATURITY; PRIORITY JOURNAL; SCORING SYSTEM; SENSORY SYSTEM;

ADOLESCENT; APNEA; BRONCHODILATOR AGENTS; CEREBRAL PALSY; CHILD DEVELOPMENT; DEVELOPMENTAL DISABILITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; MALE; PSYCHOLOGICAL TESTS; SURVIVORS; THEOPHYLLINE;

EID: 0033994731     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2000.00446.x     Document Type: Article

References (32)

1. Durand DJ, Goodman A, Ray P, Ballard RA, Clyman RI. Theophylline treatment in the extubation of infants weighing less than 1250 grams: A controlled trial. Pediatrics 1987; 80: 684-8.
2. Greenough A, Elias-Jones A, Pool J, Morley CJ, Davis JA. The therapeutic actions of theophylline in preterm ventilated infants. Early Hum. Dev. 1985; 12: 15-22.
3. Viscardi RM, Faix RG, Nicks JJ, Grasela TH. Efficacy of theophylline for prevention of post-extubation respiratory failure in very low birth weight infants. J. Pediatr. 1985; 107: 469-72.
4. Gupta JM, Mercer HP, Koo WWK. Theophylline in treatment of apnea of prematurity. Aust. Paediatr. J. 1981; 17: 290-1.
5. Murat I, Moriette G, Blin MC et al. The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants. J. Pediatr. 1981; 99: 984-99.
6. Peliowski A, Finer NN. A blinded, randomized, placebocontrolled trial to compare theophylline and doxapram for the treatment of apnea of prematurity. J. Pediatr. 1990; 116: 648-53.
7. Sims ME, Yau G, Rambhatla S, Cabal L, Wu PYK. Limitations of theophylline in the treatment of apnea of prematurity. Am. J. Dis. Child. 1985; 139: 567-70.
8. Henderson-Smart DJ, Davis PG. Prophylactic methylxanthine for extubation in preterm infants (Cochrane review). The Cochrane Library, Issue 2 (updated quarterly). Update Software, Oxford, 1998.
9. Henderson-Smart DJ, Steer P. Methylxanthine treatment for apnea in preterm infants (Cochrane review). The Cochrane Library, Issue 2 (updated quarterly). Update Software, Oxford, 1998.
10. Piecuch RE, Leonard CH, Ballard RA, Clyman RI. Neurodevelopmental outcome of very low birthweight VLBW = < 1000 g infants treated with theophylline (T) to facilitate extubation. Pediatr. Res. 1989; 25: 261A.
11. Gunn TR, Metrakos K, Riley P, Willis D, Aranda J. Sequelae of caffeine treatment in preterm infants with apnea. J. Pediatr. 1979; 94: 106-9.
12. Ment LR, Scott DT, Ehrenkranz RE, Duncan CC. Early developmental follow-up of infants with GMH/IVH: Effect of methylxanthine therapy. Am. J. Perinatol. 1985; 2: 223-7.
13. Nelson RM, Resnick MB. Long-term outcome of premature infants treated with theophylline. Sem. Perinatol. 1981; 5: 370-3,
14. Kitchen WH, Doyle LW, Ford GW, Rickards AL, Lissenden JV, Ryan MM. Cerebral palsy in very low birthweight infants surviving to 2 years with modern perinatal intensive care. Am. J. Perinatol. 1987; 4: 29-35.
15. Kitchen WH, Yu VYH, Lissenden JV, Bajuk, B. Collaborative study of very-low-birthweight infants: Techniques of perinatal care and mortality. Lancet 1982; i: 1454-7.
16. Murton LJ, Butt WW, Mackay RJ, Roy RND, de Crespigny LCh. Perinatal factors, periventricular haemorrhage and mortality in very low birthweight infants. Aust. Paediatr. J. 1985; 21: 39-43.
17. Kitchen WH, Ford GW, Murton LJ et al. Mortality and two year outcome of infants of birthweight 500-1500 g: Relationship with neonatal cerebral ultrasound data. Aust. Paediatr. J. 1985; 21: 253-9.
18. Kitchen WH, Ford GW, Rickards AL, Doyle LW, Kelly E, Murton LJ. Five-year outcome of infants of birthweight 500-1500 grams: Relationship with neonatal ultrasound data. Am. J. Perinatol. 1990; 7: 60-5.
19. Freeman JV, Cole TJ, Chinn S, Jones PRM, White EM, Preece MA. Cross-sectional stature and weight reference curves for the UK, 1990. Arch. Dis. Child. 1995; 73: 17-24.
20. Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK, 1990. Arch. Dis. Child. 1995; 73: 25-9.
21. Stott DH, Moyes FA, Henderson SE. Test of Motor Impairment (Revised by Henderson SE). Brook Educational, Guelph, 1984.
22. Wechsler D. Wechsler Intelligence Scale for Children - 3rd Edn. The Psychological Corporation. Harcourt Brace Jovanovich Inc., San Antonio, 1991.
23. Daniel A. Power, Privilege and Prestige: Occupations in Australia. Longman Cheshire, Sydney, 1983.
24. SPSS for Windows. Statistical Computer Program: Version 6.1.3. SPSS Inc. Chicago, 1995.
25. National Institutes of Health Consensus Development Panel on infantile apnea and home monitoring, Sept 29 to Oct 1 1986. Pediatrics 1987; 79: 292-9.
26. Nehlig A, Daval J-L, Debry G. Caffeine and the central nervous system: Mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res. Dev. Brain Res. 1992; 80: 139-70.
27. Howell J, Clozel M, Aranda JV, Adverse effects of caffeine and theophylline in the newborn infant. Sem. Perinatol. 1981; 5: 359-69.
28. 1-adenosine receptor gene expression in fetal rat brain. Brain Res. Dev. Brain Res. 1996; 94: 205-23.
29. 1 adenosine receptor ontogeny using autoradiography. Brain Res. Dev. Brain Res. 1994; 8: 223-30.
30. Thurston-JH Hauhard-RE, Dirgo JA. Aminophylline increases cerebral metabolic rate and decreases anoxic survival in young mice. Science 1978; 201: 649-51.
31. 2 levels, and neurodevelopmental sequelae following assisted ventilation. Clin, Perinatol. 1998; 25: 159-75.
32. Allan WC, Vohr B, Makuch RW, Katz KH, Ment LR. Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhage. Arch. Pediatr. Adolesc. Med. 1997; 151: 580-5.